Stay updated on Binimetinib Combo in RAS+ MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page.

Latest updates to the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedExpanded the Locations section with new study sites across the United States and internationally (California, Delaware, District of Columbia, Florida, Indiana, Missouri, Pennsylvania, Tennessee, Texas, North Holland, London - City of, Oxfordshire, Sutton) and updated the page to Revision: v3.3.3. The older revision entries (v3.3.2) were removed and the HHS Vulnerability Disclosure reference was deleted.SummaryDifference1.0%

- Check55 days agoChange DetectedPublication notes updated: PubMed-sourced publications are now described as automatically filled in, and a Revision: v3.3.2 tag was added, replacing the earlier wording and the Revision: v3.2.0 tag.SummaryDifference0.1%

- Check62 days agoChange DetectedThe header-level notice about government funding and potential outages was removed from the page, while the rest of the study details page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedNo additions or deletions were detected on the page; the study record content remains unchanged.SummaryDifference0.3%

- Check105 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Binimetinib Combo in RAS+ MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Binimetinib Combo in RAS+ MSS mCRC Clinical Trial page.